We Do Data Right.

Publications

Recent Publications

    1. Gwadry-Sridhar F. Commentary Real-World Data Should Drive Obesity Drug Use. MedNous January 2025. Full article
    2. Cheema PK, Syed I, Gwadry-Sridhar F, Rakibuz-Zaman M, Sachdeva R, Pencz A, Zhan L, Hueniken K, Patel D, Balaratnam K, Khan K, Grant B, Sheffield B, Locke MEO, Moldaver D, Shanahan MK, Liu G, Kuruvilla MS. Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Smal Cell Lung Cancer: A Real-World Study. Curr. Oncol. 2024, 31,6735–6748. https://doi.org/10.3390/curroncol31110497 
    3. Strum S, Climans S, Purcell V, Black M, Winquist E, Ernst S. Real-World Experience With Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma. Journal of Cutaneous Medicine and Surgery. 2024;0(0). doi:10.1177/12034754241265696
    4. Amzal B, Magnard F, Mason M, Loustalot P, Young L, Tornqvist M, Gwadry – Sridhar F. Machine Learning (ML) Applied to Real-World Data to Guide Prescription of Immune-Therapies in Metastatic Melanoma: A Pilot Study. ISPOR (2023): Poster Presentation (RWD123). https://www.ispor.org/heor-resources/presentations-database/presentation/intl2023-3668/126669  
    5. Henderson J, Proulx K, Fillingham S, Gwadry-Sridhar F.  Real-World Data (RWD) Collection and Innovative Decentralized Approaches – Putting the Patient First and Enhancing Patient Diversity. ISPOR (2023): Poster Presentation (SA77). https://www.ispor.org/docs/default-source/intl2023/ispor23gwadry-sridharposter126796-pdf.pdf?sfvrsn=df1454f2_0  
    6. ​​Liu N, Kosinski M, Gwadry-Sridhar F.  ​Using A Centralized Platform to Integrate Retrospective and Prospective Data –Lessons Learned. ISPOR (2023): Poster Presentation (RWD111). https://www.ispor.org/docs/default-source/intl2023/ispor23liuposter127598-pdf.pdf?sfvrsn=f8cfff0d_0 
    7. Sacco, J. J., Orloff, M. M., Patel, S. P., Conway, M., Lim, L.-A., Fog, L. S., Sia, D., McKenzie, J., McKay, D., O’day, R., Isaacs, T., Shoushtari, A. N., Sullivan, R. J., Kin, S., Gwadry-Sridhar, F. H., Joshua, A. M., &Carvajal, R. D. (2022). Capturing uveal melanoma (UM) global practice patterns and clinical outcomes in the collaborative ocular melanoma natural history (OMNi) study (NCT04588662). Journal of Clinical Oncology, 40(16_suppl), TPS9610–TPS9610. https://doi.org/10.1200/JCO.2022.40.16_suppl.TPS9610

    8. Macfadden W, Whalen M, Steininger TL, Simakajornboon N, Gwadry-Sridhar F, & Owens JA. Children, Adolescents, and Their providers: the Narcolepsy Assessment Partnership (CATNAP™) Paediatric Narcolepsy Registry: Study Design. WSO 2022, Rome, Italy. Poster.

    9. Nightingale K, Henderson J, Liu N, Webb A. Launching the First Registry for Birt-Hogg-Dubé (BHD) syndrome. ECRD, 2022, Poster.
    10. Henderson J, Gwadry-Sridhar F. A novel approach at enabling the integration of additional data into the CDKL5 Registry. ECRD, 2022, Poster.
    11. Fillingham S, Henderson J, Liu N, Gwadry-Sridhar F. The rapid deployment of a rare disease community registry. ECRD, 2022, Poster
    12. Kuruvilla MS, Syed I, Gwadry-Sridhar F, Sachdeva R, Pencz A, et al. Real-world outcomes in resected stage IB-IIIA EGFR mutated NSCLC in Canada: Analysis from the POTENT study. Annals of Oncology. 2021; 32(5): S931-S932
    13. Kuruvilla MS, Syed I, Gwadry-Sridhar F, Sachdeva R, Pencz A, et al. Real-world outcomes in resected stage IB-IIIA EGFR mutated NSCLC in Canada: Analysis from the POTENT study. ESMO Congress 2021, Paris, France. Poster and oral presentation
    14. Ernst DS, McConkey H, Gwadry-Sridhar F, Butler M, Baetz T, et al. Utilization of Real World Data to Assess the Efficacy of Immune Checkpoint Inhibitors (ICI) in Elderly Patients with Metastatic Melanoma. ESMO 2019, Barcelona, Spain. Poster and oral presentation
    15. Jansen RJ, Tong M, Argos M, Jasmine F, Rakibuz-Zaman M, et al. The effect of age on DNA methylation in whole blood among Bangladeshi men and women. BMC Genomics. 2019; 20:704.
    16. Pierce BL, Tong L, Dean S, Argos M, Jasmine F, et al. A missense variant in FTCD is associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet. 2019; 15(5): e1008172

Cutaneous Melanoma

  • Lenehan JG, Ernst DS, Young LC, Cronin A, Butler MO, Petrella TM, Baetz TD, Song X, Cheng T, Walker J, Lee LM, Melvin JE, Rajagopal S, Gwadry-Sridhar FH. (2024). Prospective real-world evidence for the use of immune-checkpoint inhibitors and BRAF-targeted therapy in advanced melanoma from a large Canadian cohort. J. Clin. Oncol, 42((16_suppl):e21533-e21533). https://doi.org/10.1200/JCO.2024.42.16_suppl.e21533  
  • Kartolo A, Deluce J, Hopman WM, Liu L, Baetz T, Ernst S, Lenehan JG. Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma. Curr Oncol. (2022) Mar; 29(3): 1501–1513.  https://doi.org/10.3390/curroncol29030126  
  • Kartolo BA, Deluce J, Hopman WM, Liu L, Baetz TD, Ernst DS, Lenehan JG. Impact of systemic therapy sequencing on overall survival for patients with advanced BRAF-mutated melanoma. J. Clin. Oncol. (2021, May); 39 (15_Suppl, 9552-9552).  DOI:  https://doi.org/10.1200/JCO.2021.39.15_suppl.9552  
  • Ernst, DS, McConkey, H, Liu L, Butler, MO, Petrella T, Baetz T,  Koneru X, Song X, Cheng T, Smylie MG, Rajagopal S, Mihalcioiu C, Gwadry-Sridhar, F. 1354P. Utilization of Real-World Data to Assess the Effectiveness of Immune Checkpoint Inhibitors (ICIs) in Elderly Patients with Metastatic Melanoma. Ann. Oncol.(2019);30( Suppl 5, v553). https://doi.org/10.1093/annonc/mdz255.042  
  • Ernst, D., Hayward, V., McConkey, H., Teng, X., Saettler, E., Cheng, T., Temple-Oberle, C., & Gwadry-Sridhar, F. (2018). Impact of Intralesional Interleukin 2 (IL2) for In-transit Melanoma in two Canadian Centres | Ann. Oncol.(2018);29( Suppl 8, viii447-viii448). DOI: https://doi.org/10.1093/annonc/mdy289.011    
  • Gwadry-Sridhar, F., McConkey, H., Teng, X., & Ernst, D. The National Melanoma Research Registry: a fundamental for disease characterization and epidemiology | (2018). Ann. Oncol.(2018);29( Suppl 8, viii460). DOI: https://doi.org/10.1093/annonc/mdy289.044  
  • Ernst, D., Koneru, R., Song, X., Cheng, T., Petrella, T., Smylie, M., Rajagopal, S., Mihalcioiu, C., & Gwadry-Sridhar, F. Utilization of Real World Data to Assess the Efficacy of Immune Checkpoint Inhibitors (ICI) in Elderly Patients with Metastatic Melanoma. (2018). SMR-15th International Congress, Manchester, England, p46–46. https://www.societymelanomaresearch.org/docs/congress/congress_abstracts_2018.pdf  
  • Teng, X., Gwadry, F., McConkey, H., Ernst, S., & Gwadry-Sridhar, F. An adaptive treatment recommendation and outcome prediction model for metastatic melanoma. (2018, November 24). 32nd Conference on Neural Information Processing Systems (NIPS 2018), Montréal, Canada. http://arxiv.org/abs/1811.09851 
  • Gwadry-Sridhar, F., Nikan, S., Hamou, A., Seung, S. J., Petrella, T., Joshua, A. M., Ernst, S., & Mittmann, N. Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study. (2017). Current Oncology (Toronto, Ont.), 24(3), 168–175.  https://doi.org/10.3747/CO.24.3432  
  • Ernst, D. S., Petrella, T., Joshua, A., Cheng, T., Smylie, M., Baetz, T., Hamou, A., & Gwadry-Sridhar, F. Impact of ipilimumab on metastatic melanoma: Evaluation using patient registry in Canada (melanoma and other skin tumours 1122P). (ESMO 2016).  Abstract Book of the 41st ESMO Congress, 7-11 October 2016, Copenhagen, Denmark, 27, vi384. https://doi.org/10.1093/annonc/mdw379.17 

Non-Melanoma Cutaneous Malignancies

  • Mitchell B, Behling M, Logan D, Lenehan J, and Ernst SE. Single-centre experience with multi-modality treatment of patients with Merkel cell carcinoma between 2010 and 2022. Canadian Melanoma Conference, February 23-25, 2023, Banff AB, Canada. Full Publication and Poster
  • Tong J, Mitchell B, Roth K, Logan D, Ernst S. Real-World Experience of Vismodegib in Advanced Basal Cell Carcinoma at a Canadian Cancer Center. J Cutan Med Surg. 2022 Mar-Apr;26(2):143-148. doi: 10.1177/12034754211051234. Epub 2021 Oct 19. PMID: 34663118. https://journals.sagepub.com/doi/10.1177/12034754211051234
  • Strum S, Climans S, Purcell VA, Black M, Ernst SE. Real world experience of cemiplimab in the treatment of refractory locally-advanced and metastatic cutaneous squamous cell carcinoma. Journal of Cutaneous Medicine and Surgery. 2024;0(0). doi:10.1177/12034754241265696 https://journals.sagepub.com/doi/10.1177/12034754241265696

Uveal Melanoma

  • Sacco JJ, Butler M, Khan S, Orloff M, Patel SP, Shoushtari A, Sullivan R., Proudfoot-Jones J, Lim L-A, Shackleton M, Shaw H, Garadi K, Schulz E, Young LC, Gwadry-Sridhar FH, Joshua AM, Carvajal RC. Characteristics and outcomes in patients with early or late distant recurrence of uveal melanoma: Analysis from the Ocular Melanoma Natural History (OMNi) Study. 2024 Society for Melanoma Research Congress, October 10-14, 2024, New Orleans LA. Full Poster
  • Lim L-A, Marr B, Krema H, Shields C, Conway M, Young LC, OMNi Consortium Investigators. Characteristics and Outcomes of Patients with Early or Late Uveal Melanoma Metastasis: Analysis from the Ocular Melanoma Natural History (OMNI) Study. International Society of Ocular Oncology (ISOO) 2024 Conference, December 3-7, 2024, Goa India. 
  • Sacco JJ, Orloff MM, Patel SP, Conway M, Lim L-A, Fog LS, Sia D, McKenzie J, McKay D, O’Day R, Isaacs T, Shoushtari AN, Sullivan RJ, Kin S, Gwadry-Sridhar FH, Joshua AM, Carvajal RD. (2022). Capturing uveal melanoma (UM) global practice patterns and clinical outcomes in the collaborative ocular melanoma natural history (OMNi) study (NCT04588662). Journal of Clinical Oncology, 40(16_suppl), TPS9610–TPS9610. https://doi.org/10.1200/JCO.2022.40.16_suppl.TPS9610  

Lung Cancer

  • Cheema PK, Syed I, Gwadry-Sridhar F, Rakibuz-Zaman M, Sachdeva R, Pencz A, Zhan L, Hueniken K, Patel D, Balaratnam K, et al. Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study. Current Oncology. 2024; 31(11):6735-6748. https://doi.org/10.3390/curroncol31110497 
  • Kuruvilla S, Wheatley-Price P, Gwadry Sridhar FH, Joubert P, Aseyev OI, Young LC, Sachdeva R, Sheffield B, Richardson M, Bafaro J,  Seeger R, Wojtyk A, Bisson K,Foo A, Liu G, Cheema PK. Pan-Canadian Lung Cancer Observational Study (PALEOS): A Multicentre Ambispective Observational Study of Lung Cancer Patients. 2024 World Conference on Lung Cancer, September 7-10, 2024, San Diego CA. Full poster.
  • Kuruvilla MS, Liu G, Syed I, Gwadry-Sridhar F, Sheffield BD, Sachdeva R, Pencz  A, Zhan L, Hueniken K, Patel D, Balaratnam K, Khan K, Grant B, Noy S, Singh K, Liu L, Rakibuz-Zaman M, Moldaver D, Shanahan MK, Cheema PK. EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada. Lung Cancer. 2022 Nov; 173:58-66. https://pubmed.ncbi.nlm.nih.gov/36152478/  
  • Kuruvilla MS, Syed I, Gwadry-Sridhar F, Sachdeva R, Pencz A, Zhan L, Hueniken K, Patel D, Balaratnam K, Khan K, Grant B, Noy S, Singh K, Liu L, Rakibuz-Zaman M, Davis B,  Moldaver D, Shanahan MK, Cheema PK. Real-world outcomes in resected stage IB-IIIA EGFR mutated NSCLC in Canada: Analysis from the POTENT study. ESMO Congress 2021, Paris, France. Poster and oral presentation. https://doi.org/10.1016/j.annonc.2021.08.1755    
  • Cheema PK, Syed I, Gwadry-Sridhar F, Rakibuz-Zaman M, Sachdeva R, Pencz  A, Zhan LJ, Hueniken K, Patel D, Balaratnam K, Khan K, Grant B, Noy S, Singh K, Sheffield BD, Locke B, Moldaver D, Shanahan MK, Liu G, Kuruvilla MS.  Programmed death-ligand 1 (PDL1) expression and real world outcomes in resected, early-stage non-small cell lung cancer (NSCLC). Ann. Oncol. 2022 Sep; 33:(S7). https://doi.org/10.1016/j.annonc.2022.07.1065 

Apps for Care in the Home

  1. Hiligsmann M, Salas M, Hughes DA, Manias E, Gwadry-Sridhar FH, Linck P, Cowell W. Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporosis International 2013; 24(12): 2907-2918 (Abstract)
  2. Hamou A, Guy S, Lewden B, Bilyea A, Gwadry-Sridhar F, Bauer MA. Data collection with iPhone Web apps efficiently collecting patient data using mobile devices. IEEE 12th International Conference on e-Health. Lyon France. July, 2010. (Poster)

Chronic Disease Research

  1. An JJ, Gwadry-Sridhar F. Systematic Review of the Psychometric Properties of the Functional Assessment of Cancer Therapy – Anemia (Fact-AN) for Anemic Cancer Patients. ISPOR 13th Annual International Meeting (Toronto, Canada. May 3-7, 2008). Value in Health. 2008; 11(3):A164, PSY40. (Abstract)
  2. Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, Parvez F, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Slavkovich V, van Geen A, Graziano J, Ahsan H. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet. 2010 Jul 24;376(9737):252-8. doi: 10.1016/S0140-6736(10)60481-3. Epub 2010 Jun 18
  3. Argos M, Melkonian S, Parvez F, Rakibuz-Zaman M, Ahmed A, Chen Y, Ahsan H. A population-based prospective study of energy-providing nutrients in relation to all-cause cancer mortality and cancers of digestive organs mortality. Int J Cancer. 2013 Nov 15;133(10):2422-8. doi: 10.1002/ijc.28250. Epub 2013 May 29
  4. Argos M, Parvez F, Rahman M, Rakibuz-Zaman M, Ahmed A, Hore SK, Islam T, Chen Y, Pierce BL, Slavkovich V, Olopade C, Yunus M, Baron JA, Graziano JH, Ahsan H. Arsenic and lung disease mortality in Bangladeshi adults. Epidemiology. 2014 Jul;25(4):536-43. doi: 10.1097/EDE.0000000000000106
  5. Argos M, Rahman M, Parvez F, Dignam J, Islam T, Quasem I, K Hore S, T Haider A, Hossain Z, I Patwary T, Rakibuz-Zaman M, Sarwar G, La Porte P, Harjes J, Anton K, Kibriya MG, Jasmine F, Khan R, Kamal M, Shea CR, Yunus M, Baron JA, Ahsan H. Baseline comorbidities in a skin cancer prevention trial in Bangladesh. Eur J Clin Invest. 2013 Jun;43(6):579-88. doi: 10.1111/eci.12085. Epub 2013 Apr 17
  6. Bienek AS, Gee ME, Nolan RP, Kaczorowski J, Campbell NRC, Bancej C, Gwadry-Sridhar F, Robitaille C, Walker RL, Dai S. Methodology of the 2009 Survey on Living with Chronic Diseases in Canada – hypertension component. Chronic Diseases and Injuries in Canada (CDIC). 2013 Sept; 33(4): 267-76. (Abstract)
  7. Chen Y, Ge W, Parvez F, Bangalore S, Eunus M, Ahmed A, Islam T, Rakibuz-Zaman M, Hasan R, Argos M, Levy D, Sarwar G, Ahsan H. A prospective study of arm circumference and risk of death in Bangladesh. Int J Epidemiol. 2014 Aug;43(4):1187-96. doi: 10.1093/ije/dyu082. Epub 2014 Apr 7
  8. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, Argos M, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Levy D, van Geen A, Ahsan H. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ. 2011 May 5;342:d2431. doi: 10.1136/bmj.d2431
  9. Dai P, Gwadry-Sridhar F, Bauer M, & Borrie M. Brain Degeneration: How Alzheimer’s Disease Affects the Human Brain, in Aging and Society: Fifth Interdisciplinary Conference, Washington D.C., USA, 5-6 November, 2015. (Abstract)
  10. Demers C, Patterson C, Archer N, Coallier J, Strachan P, Keshaviee K, L. Thabane L, Spencer F, Cockhill C, Foster G, & Gwadry-Sridhar F. A Simple Multi-Component Intervention Improves Self Management In Heart Failure. Canadian Journal of Cardiology (CCC). October 2014; 30(10): S201 (Abstract)
  11. Demers C, Patterson C, Archer N, Coallier J, Strachan P, Keshaviee K, L. Thabane L, Spencer F, Cockhill C, Foster G, & Gwadry-Sridhar F. Simple Multi-Component Intervention Improves Self Management in Heart Failure, Canadian Cardiovascular Congress (CCC), October 2014, (Abstract)
  12. Gee ME, Bienek A, Campbell NRC, Bancej CM, Robitaille C, Kaczorowski J, Joffres M, Dai S, Gwadry-Sridhar F, Nolan RP. Prevalence of, and Barriers to, Preventive Lifestyle Behaviors in Hypertension (from a National Survey of Canadians With Hypertension). American Journal of Cardiology. Feb 15 2012; 109(4): 570-5. (Paper)
  13. Gee ME, Campbell NRC, Gwadry-Sridhar F, Nolan RP, Kaczorowski J, Bienek A, Robitaille C, Joffres M, Dai S, Walker RL Antihypertensive Medication Use, Adherence, Stops and Starts in Canadians With Hypertension. Can J Cardiol. May-June, 2012; 28(3): 383-389 (Paper)
  14. Guy S, Ratzki-Leewing A, Gwadry-Sridhar F. Moving Beyond the Stigma: Systematic review of Video Games and Their Potential to Combat Obesity. Int J Hypertens. 2011; 2011: 179124. (Paper)
  15. Guy SD, Gwadry-Sridhar F. Participant’s Experiences of a Web-Based Portal for Chronic Disease Management. The 32nd Annual Meeting of the Society for Medical Decision Making (Toronto, Canada. October 24-27, 2010). (Abstract)
  16. Gwadry-Sridhar F, Flintoft V, Lee DS, Lee H, Guyatt GH. A systematic Review and Meta-analysis of Studies Comparing Readmission Rates and Mortality Rates in Patients With Heart Failure. Arch Intern Med. 2004 Nov 22; 164(21):2315-20. (Paper)
  17. Gwadry-Sridhar F, Guyatt G, O’Brien B, Arnold JM, Walter S, Vingilis E, MacKeigan L. TEACH: Trial of Education and Compliance in heart dysfunction chronic disease and heart failure (HF) as an increasing problem. Contemp Clin Trials. 2008 Nov; 29(6):905-18. (Paper)
  18. Gwadry-Sridhar F, Guyatt GH, Arnold JM, Massel D, Brown J, Nadeau L, Lawrence S. Instruments to measure acceptability of information and acquisition of knowledge in patients with heart failure. Eur J Heart Fail. 2003 Dec; 5(6): 783-91. (Paper)
  19. Gwadry-Sridhar F, Hamou A, Guy S, O’Brien J, Spence D. Integrated Electronic Medical Health Record Informatics Platform for Stroke and Atherosclerosis Research. Med-e-Tel 2011 (Abstract)
  20. Gwadry-Sridhar F, Leslie RS, Patel B, Aranda G, Sanchez-Trask L. Influence of Previous Medication Compliance on Future Compliance in Patients with Type 2 Diabetes. American Diabetes Association, 2010. (Poster)
  21. Gwadry-Sridhar F, Leslie RS, Patel B, Sanchez-Trask L. Understanding Predictors of Compliance in Fixed-Dose Combination vs Loose-Dose Combination Therapy for Treatment of Type 2 Diabetes. American Diabetes Association, 2010. (Poster)
  23. Gwadry-Sridhar F, Martin C, Chen L, Priestap F, Keenan S. Criteria for Assessing Intensive Care Unit Admissions from the Emergency Room. Value in Health. 2001; 4(6); 481, #PHP24. (Abstract)
  24. Gwadry-Sridhar F, Zhang Y, Manias E, Roy AN, Yu-Isenberg K, Hughes D, Nichol MB. A framework for planning and critiquing medication compliance and persistence research using prospective study designs. Clin Ther. 2009 Feb; 31(2):421-35. (Paper)
  25. Gwadry-Sridhar FH, Arnold JM, Zhang Y, Brown JE, Marchiori G, Guyatt G. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J. 2005 Nov; 150(5):982. (Paper)
  26. Hamade N, Hodge WG, Rakibuz-Zaman M, Malvankar-Mehta MS. The Effects of Low-Vision Rehabilitation on Reading Speed and Depression in Age Related Macular Degeneration: A Meta-Analysis. PLoS One. 2016 Jul 14;11(7):e0159254. doi: 10.1371/journal.pone.0159254. eCollection 2016
  27. Hamou A, Guy S, Lewden B, Bilyea A, Gwadry-Sridhar F, Bauer MA. Data collection with iPhone Web Apps: Efficiently Collecting Patient Data Using Mobile Devices. E-Health Networking Applications and Services (Healthcom), August 2010. (Poster)
  28. Hamou AK, Lindsay JD, Borrie MJ, and Gwadry-Sridhar F. Platform for a Longitudinal Clinical Research Registry System granor the Care of Outpatients Referred with Cognitive Impairment/Dementia. Canadian Geriatrics Journal. December 2013; 16(4): 220. (Abstract)
  29. Hiligsmann M, Salas M, Hughes D, Manias E, Gwadry-Sridhar F, Cowell W. Cost to society due to underemployment in persons with Hemophilia A and B – Hemophilia Utilization Group Study (HUGS V). ISPOR 18th Annual International Meeting Research Poster Presentations – Session II, May 2013; 16(3): A119-A120 (Abstract)
  30. Hiligsmann M, Salas M, Hughes DA, Manias E, Gwadry-Sridhar F, Linck P, Cowell W. Most effective adherence-enhancing interventions for osteoporosis medications. ISPOR 16th Annual International Meeting. Value in Health. May 24, 2011; 14(3):A130, PMS39. (Abstract)
  31. Hiligsmann M, Salas M, Hughes DA, Manias E, Gwadry-Sridhar FH, Linck P, Cowell W. Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporosis International 2013; 24(12): 2907-2918 (Abstract)
  32. Jansen RJ, Argos M, Tong L, Li J, Rakibuz-Zaman M, Islam MT, Slavkovich V, Ahmed A, Navas-Acien A, Parvez F, Chen Y, Gamble MV, Graziano JH, Pierce BL, Ahsan H. Determinants and Consequences of Arsenic Metabolism Efficiency among 4,794 Individuals: Demographics, Lifestyle, Genetics, and Toxicity. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):381-90. doi: 10.1158/1055-9965.EPI-15-0718. Epub 2015 Dec 16
  33. Kawatkar AA, Gwadry-Sridhar F. A Systematic Review of the EORTIC QLQ-BR23: Descriptive Health Related Quality of Life Instrument Used in Breast Cancer. Value in Health. May-June 2006; 9(3): A11, PCN43. (Abstract)
  34. Leslie RS, Gwadry-Sridhar F, Thiebaud P, Patel BV. Calculating edication compliance, adherence, and persistence in administrative pharmacy claims databases. Pharmaceutical Programming 2008; 1(1):13-19. (Paper)
  35. McClintock TR, Chen Y, Parvez F, Makarov DV, Ge W, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Slavkovich V, Bjurlin MA, Graziano JH, Ahsan H. Association between arsenic exposure from drinking water and hematuria: results from the Health Effects of Arsenic Longitudinal Study. Toxicol Appl Pharmacol. 2014 Apr 1;276(1):21-7. doi: 10.1016/j.taap.2014.01.015. Epub 2014 Jan 28
  36. Mertens WC, Bramwell VH, Banerjee D, Gwadry-Sridhar F, Lala PK. Sustained indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced malignant melanoma: a phase II study. Clin Oncol (R Coll Radiol). 1993; 5(2):107-13. (Paper)
  37. Mertens WC, Bramwell VH, Gwadry-Sridhar F, Romano W, Banerjee D, Lala PK. Effect of indomethacin plus ranitidine in advanced melanoma patients on high dose interleukin-2. Lancet. 1992 Aug 15; 340(8816):397-8. (Abstract)
  38. Nolan RP, Payne AY, Ross H, White M, D’Antono B, Chan S, Barr SI, Gwadry-Sridhar F, Nigam A, Perreault S, Farkouh M, McDonald M, Goodman J, Thomas S, Zieroth S, Isaac D, Oh P, Rajda M, Chen M, Eysenbach G, Liu S, Zbib A. An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure: Randomized Controlled Trial Protocol, JMIR Res Protoc 2014;3(1):e5 (Paper)
  39. Peterson AM, Nau DP, Cramer JP, Benner J, Gwadry-Sridhar F, Nichol M. A Checklist for Medication Compliance and Persistence Studies using Retrospective Databases. Value in Health. January-February 2007; 10(1): 3-12 (Paper)
  40. Pierce BL, Kalra T, Argos M, Parvez F, Chen Y, Islam T, Ahmed A, Hasan R, Rakibuz-Zaman M, Graziano J, Rathouz PJ, Ahsan H. A prospective study of body mass index and mortality in Bangladesh. Int J Epidemiol. 2010 Aug;39(4):1037-45. doi: 10.1093/ije/dyp364. Epub 2009 Dec 23
  41. Poon JL, Lou M, Zhou ZY, Gwadry-Sridhar F, Baker J, Ullman M, Koerper M, Johnson K. The Hemophilia Utilization Group Study (HUGS-VB): Health-related quality of life in hemophilia B. ISPOR 16th Annual International Meeting (Baltimore, Maryland, United States. May 25, 2011). Value in Health. 2011; 14(3): A210, PND47. (Abstract)
  42. Rahman M, Rahman MA, Flora MS, Rakibuz-Zaman M. Depression and associated factors in diabetic patients attending an urban hospital of Bangladesh. International Journal of Collaborative Research on Internal Medicine & Public Health. 2011; 3:65-76
  43. Rakibuz-Zaman M and Hodge W (2018). Herpetic Keratouveitis (Chapter 3). In Garg SJ (Ed.) Color Atlas & Synopsis of Clinical Ophthalmology: Uveitis (2nd Ed). Philadelphia PA. Walters Kluwer
  44. Skillings JR, Gwadry-Sridhar F, Wong C, et al. The Frequency of Red Cell Transfusion for Anemia in Patients Receiving Chemotherapy A Retrospective Cohort Study. The American J of Clin Oncol. 1993; 16(1):22-25. (Paper)
  45. Skillings JR, Rogers-Melamed I, Nabholtz JM, Sawka C, Gwadry-Sridhar F, Moquin JP, Rubinger M, Ganguly P, Burnell M, Shustik C, Dryer D, McLaughlin M, White D. An epidemiological review of red cell transfusions in cancer chemotherapy. Cancer Prev Control. 1999 June; 3(3): 207-12. (Paper)
  46. Spenger C , Eskildsen S, Sjogren N, Julin P, Westman E, Wahlund LO, Gwadry-Sridhar F, Muehlboech S, Lovestone S, Simmons A,. Cortical atrophy rates in Alzheimer’s disease and mild cognitive impairment from the ADNI study. Alzheimers & Dementia. July 2011, 7(4): S225. (Abstract)
  47. Stafkey-Mailey DR, Gwadry-Sridhar F. A Review of the Validity and Reliability of the Parkinson’s Disease Questionnaire (PDQ-39). Value in Health. May-June 2006; 9(3): A88, PNL29, (Abstract)
  48. Westman E, Simmons A, Muehlboeck JS, Gwadry-Sridhar F, Eskildsen SF, Julin P, Sjögren N, Collins DL, Evans A, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner M, Lovestone S, Spenger C, Wahlund LO, AddNeuroMed consortium. Combining Two Large MRI Data Sets (AddNeuroMed and ADNI) Using Multivariate Data Analysis to Distinguish between Patients with Alzheimer’s Disease and Healthy Controls. Alzheimer’s Association International Conference on Alzheimer’s Disease (2010) IC-P-137. (Abstract)
  49. White JA, Kim HW, Shah D, Fine N, Kim KY, Wendell DC, Al-Jaroudi W, Parker M, Patel M, Gwadry-Sridhar F, Judd RM, Kim RJ. CMR Imaging With Rapid Visual T1 Assessment Predicts Mortality in Patients Suspected of Cardiac Amyloidosis. JACC: Cardiovascular Imaging. Feb 2014; 7(2): 143-156. (Paper)
  50. Wu F, Chen Y, Parvez F, Segers S, Argos M, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Ahsan H. A prospective study of tobacco smoking and mortality in Bangladesh. PLoS One. 2013;8(3):e58516. doi: 10.1371/journal.pone.0058516. Epub 2013 Mar 11
  51. Wu F, Chi L, Ru H, Parvez F, Slavkovich V, Eunus M, Ahmed A, Islam T, Rakibuz-Zaman M, Hasan R, Sarwar G, Graziano JH, Ahsan H, Lu K, Chen Y. Arsenic Exposure from Drinking Water and Urinary Metabolomics: Associations and Long-Term Reproducibility in Bangladesh Adults. Environ Health Perspect. 2018 Jan 12;126(1):017005. doi: 10.1289/EHP1992
  52. Wu J, Nichol MB, Gwadry-Sridhar F, Johnson KA. The Hemophilia Utilization Group Study – Part V. Estimating Utility Values for Self-Reported Joint Pain and Motion Limitation Outcomes in Adult Hemophilia Patients. Value in Health. May-June 2007; 10(3):A155, PHM8. (Abstract)
  53. Yinon L, Chen Y, Parvez F, Bangalore S, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Ahsan H. A prospective study of variability in systolic blood pressure and mortality in a rural Bangladeshi population cohort. Prev Med. 2013 Dec;57(6):807-12. doi: 10.1016/j.ypmed.2013.09.006. Epub 2013 Sep 16
  54. Yu AP, Yu YF, Nichol MB, Gwadry-Sridhar F. Delay in filling the initial prescription for a statin: a potential early indicator of medication non persistence. Clin Ther. 2008 Apr; 30(4):761-74; discussion 716. (Paper)
  55. Zhang Y, Cabilio P, Grubisic M, Gwadry-Sridhar F. A Mixture Distribution Approach to Assessing Medication Refill Compliance with Administrative Pharmacy Refill Records. Statistics in Biopharmaceutical Research, ISBS Special Issue 2009. (Paper)
  56. Zuluaga A, Salas M, Gwadry-Sridhar F, Manias E, Hughes D. Interventions to Improve Compliance with Lipid Lowering Medications: A Systematic Review of the Literature. Value in Health. May 2010; 13(3): A168 (Abstract)

Economics

  1. Gwadry-Sridhar F, Arnold M, Weaver B, Guyatt G. Does Compliance with ACE-I, Digoxin and Spironolactone Influence the Time to Event in Patients with Heart Failure. Value in Health. 2002; 5(6), PCV37. (Abstract)
  2. Hiligsmann M, Salas M, Hughes D, Manias E, Gwadry-Sridhar F, Cowell W. Cost to society due to underemployment in persons with Hemophilia A and B – Hemophilia Utilization Group Study (HUGS V). ISPOR 18th Annual International Meeting Research Poster Presentations – Session II, May 2013; 16(3): A119-A120 (Abstract)
  3. Lou M, Zhou ZY, Gwadry-Sridhar F, Poon JL, Doctor J, Koerper M, Ullman M, Johnson K. Utilizing a Paper Standard Gamble Instrument to Assess Health Utility in Patients with Hemophilia B. Value in Health. May 2011; 14(3): A208, PND33, 2011. (Abstract)
  4. Niu X, Poon JL, Lou M, Ullman M, Koerper M, Baker J, Hord J, Konkle BA, Riske B, Buranahirun C, Gwadry-Sridhar F, Curtis RG, Kulkami R, Soni A, Nichol M. Burden of Bleeding Episodes Among Persons with Hemophilia B. NHF 65th Annual Meeting. Anaheim, CA. 2013 (Poster)
  5. Poon JL, Zhou ZY, Doctor JWU, Ullman MM, Ross C, Riske B, Parish KL, Lou M, Koerper M, Gwadry-Sridhar F, Forsberg AD, Curtis RG, Johnson KA. Quality of Life in Haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va). Haemophilia. 2012 Sep; 18(5):699-707. (Abstract)
  6. Sridhar K, Gwadry-Sridhar F. Clinical outcomes and Costs of Drug Eluting Stents in the Cardiac Catherization Lab. Value in Health. 2003; 6(6), CV8. (Abstract)

Genomics and Bioinformatics

  1. Argos M, Chen L, Jasmine F, Tong L, Pierce BL, Roy S, Paul-Brutus R, Gamble MV, Harper KN, Parvez F, Rahman M, Rakibuz-Zaman M, Slavkovich V, Baron JA, Graziano JH, Kibriya MG, Ahsan H. Gene-specific differential DNA methylation and chronic arsenic exposure in an epigenome-wide association study of adults in Bangladesh. Environ Health Perspect. 2015 Jan;123(1):64-71. doi: 10.1289/ehp.1307884. Epub 2014 Oct 17
  2. Argos M, Kibriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M, Ahsan H. Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Cancer Epidemiol Biomarkers Prev.2006 Jul;15(7):1367-75
  3. Argos M, Tong L, Pierce BL, Rakibuz-Zaman M, Ahmed A, Islam T, Rahman M, Paul-Brutus R, Rahaman R, Roy S, Jasmine F, Kibriya MG, Ahsan H. Genome-wide association study of smoking behaviours among Bangladeshi adults. J Med Genet. 2014 May;51(5):327-33. doi: 10.1136/jmedgenet-2013-102151. Epub 2014 Mar 24
  4. Bussey K, Chin K, Lababidi S, Reimers M, Reinhold WC, Kuo W, Gwadry-Sridhar F, Ajay, et al. Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 Cell Line Panel. Mol Cancer Ther, 2006 Apr; 5(4):853-67.
  5. Dean SG, Zhang C, Gao J, Roy S, Shinkle J, Sabarinathan M, Argos M, Tong L, Ahmed A, Islam MT, Islam T, Rakibuz-Zaman M, Sarwar G, Shahriar H, Rahman M, Yunus M, Graziano JH, Chen LS, Jasmine F, Kibriya MG, Ahsan H, Pierce BL. The association between telomere length and mortality in Bangladesh. Aging (Albany NY). 2017 Jun 15;9(6):1537-1551. doi: 10.18632/aging.101246
  6. Delgado DA,chenan, C, Chen LS, Gao J, Roy S, Shinkle J, Sabarinathan M, Argos M, Tong L, Ahmed A, Islam T, Rakibuz-Zaman M, Sarwar M, Shahriar H, Rahman M, Yunus M, Jasmine F, Kibriya MG, Habibul Ahsan H, Pierce B. Genome-wide association study of telomere length among South Asians identifies a second RTEL1 association signal. J Med Genet.2017 Nov 18: 0:1–8. doi:10.1136/jmedgenet-2017-104922
  7. Gao J, Roy S, Tong L, Argos M, Jasmine F, Rahaman R, Rakibuz-Zaman M, Parvez F, Ahmed A, Hore SK, Sarwar G, Slavkovich V, Yunus M, Rahman M, Baron JA, Graziano JH, Ahsan H, Pierce BL. Arsenic exposure, telomere length, and expression of telomere-related genes among Bangladeshi individuals. Environ Res. 2015 Jan;136:462-9. doi: 10.1016/j.envres.2014.09.040. Epub 2014 Nov 25
  8. Ghahramani Seno MM, Gwadry-Sridhar F, Hu P, Scherer, SW. Neuregulin 1-alpha regulates phosphorylation, acetylation, and alternative splicing in lymphoblastoid cells. Genome. 2013 Oct; 56(10):619-25.
  9. Ghahramani Seno MM, Hu P, Gwadry-Sridhar F, Pinto D, Marshall CR, Cassalloa G, Scherer SW. Gene and miRNA Expression Profiles in Autism Spectrum Disorders. Brain Res. 2011 Mar 22; 1380: 85-97.
  10. Gwadry-Sridhar F, Sequeira PA, Hoke GH, ffrench-Mullen JMH, , Turecki G. Molecular characterization of suicide by microarray analysis. Am J Med Genet. C Semin Med Genet. 2005.
  11. Jansen RJ, Tong M, Argos M, Jasmine F, Rakibuz-Zaman M, Sarwar M, Islam MT, Shahriar H, Islam T, Rahman M, Yunus M, Kibriya MG, Baron JA, Ahsan H, Pierce BL. The effect of age on DNA methylation in whole blood among Bangladeshi men and women. BMC Genomics. 2019 September; 20:704.
  12. Jasmine F, Rahaman R, Roy S, Raza M, Paul R, Rakibuz-Zaman M, Paul-Brutus R, Dodsworth C, Kamal M, Ahsan H, Kibriya MG. Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed, paraffin-embedded paired tumor and normal tissue. BMC Res Notes. 2012 Feb 22;5:117. doi: 10.1186/1756-0500-5-117
  13. Kibriya MG, Jasmine F, Argos M, Verret WJ, Rakibuz-Zaman M, Ahmed A, Parvez F, Ahsan H. Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol Lett. 2007 Mar 8;169(2):162-76. Epub 2007 Jan 19
  14. Kibriya MG, Jasmine F, Parvez F, Argos M, Roy S, Paul-Brutus R, Islam T, Ahmed A, Rakibuz-Zaman M, Shinkle J, Slavkovich V, Graziano JH, Ahsan H. Association between genome-wide copy number variation and arsenic-induced skin lesions: a prospective study. Environ Health. 2017 Jul 18;16(1):75. doi: 10.1186/s12940-017-0283-8
  15. Kibriya MG, Raza M, Jasmine F, Roy S, Paul-Brutus R, Rahaman R, Dodsworth C, Rakibuz-Zaman M, Kamal M, Ahsan H. A genome-wide DNA methylation study in colorectal carcinoma. BMC Med Genomics. 2011 Jun 23;4:50. doi: 10.1186/1755-8794-4-50
  16. Lee JK, Bussey KJ, Gwadry-Sridhar F, Reinhold W, Riddick G, et al. Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol. 2003; 4(12):R82. Epub 2003 Nov 25.
  17. Nishizuka S, Chen ST, Gwadry-Sridhar F, Alexander J, Major SM, et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res. 2003 Sep 1; 63(17):5243-50.
  18. Pierce BL, Kibriya MG, Tong L, Jasmine F, Argos M, Roy S, Paul-Brutus R, Rahaman R, Rakibuz-Zaman M, Parvez F, Ahmed A, Quasem I, Hore SK, Alam S, Islam T, Slavkovich V, Gamble MV, Yunus M, Rahman M, Baron JA, Graziano JH, Ahsan H. Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet. 2012;8(2):e1002522. doi: 10.1371/journal.pgen.1002522. Epub 2012 Feb 23
  19. Pierce BL, Tong L, Argos M, Demanelis K, Jasmine F, Rakibuz-Zaman M, Sarwar G, Islam MT, Shahriar H, Islam T, Rahman M, Yunus M, Kibriya MG, Chen LS, Ahsan H. Co-occurring expression and methylation QTLs allow detection of common causal variants and shared biological mechanisms. Nat Commun. 2018 Feb 23;9(1):804. doi: 10.1038/s41467-018-03209-9
  20. Pierce BL, Tong L, Argos M, Gao J, Farzana J, Roy S, Paul-Brutus R, Rahaman R, Rakibuz-Zaman M, Parvez F, Ahmed A, Quasem I, Hore SK, Alam S, Islam T, Harjes J, Sarwar G, Slavkovich V, Gamble MV, Chen Y, Yunus M, Rahman M, Baron JA, Graziano JH, Ahsan H. Arsenic metabolism efficiency has a causal role in arsenic toxicity: Mendelian randomization and gene-environment interaction. Int J Epidemiol. 2013 Dec;42(6):1862-71. doi: 10.1093/ije/dyt182
  21. Pierce BL, Tong L, Dean S, Argos M, Jasmine F, Rakibuz-Zaman M, Sarwar G, Islam MT, Shahriar H, IslamT, Rahman M, Yunus M, Lynch VJ, Oglesbee D, Graziano JH, Kibriya MG, Gamble MV, Ahsan H. A missense variant in FTCD is associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet. 2019 May; 15(5): e1008172
  22. Scannell Bryan M, Argos M, Pierce B, Tong L, Rakibuz-Zaman M, Ahmed A, Rahman M, Islam T, Yunus M, Parvez F, Roy S, Jasmine F, Baron JA, Kibriya MG, Ahsan H. Genome-wide association studies and heritability estimates of body mass index related phenotypes in Bangladeshi adults. PLoS One. 2014 Aug 18;9(8):e105062. doi: 10.1371/journal.pone.0105062
  23. Sequeira PA, Gwadry-Sridhar F, Ffrench-Mullen JMH, Canetti L, Casero Jr RA, Turecki G. Gene expression and genetic variation implicate SSAT in suicide and major depression. Arch Gen Psychiatry. 2006 Jan; 63(1):35-48.
  24. Weinstein JN, Scherf U, Lee JK, Nishizuka S, Gwadry-Sridhar F, et al. The bioinformatics of microarray gene expression profiling. Cytometry. 2002 Jan 1; 47(1):46-9.
  25. Zhou Y, Gwadry-Sridhar F, Reinhold WC, Miller LD, Smith LH, Scherf U, Liu ET, Kohn KW, Pommier Y, Weinstein JN. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. Cancer Res. 2002 Mar 15; 62(6):1688-95.

Health Informatics Research

  1. Hamou A, O’Brien J, Guy S, Gwadry-Sridhar F. Intelligent patient management: InfoFrame – An intelligent informatics data collection framework. The 24th International Symposium on Computer-Based Medical Systems, CBMS 2011 (Bristol, United Kingdom. June 27-30, 2011). Computer-Based Medical Systems (CBMS), 2011 24th International Symposium Conference Proceedings. (Abstract)
  3. Guy SD, Gwadry-Sridhar F. Participant’s Experiences of a Web-Based Portal for Chronic Disease Management. The 32nd Annual Meeting of the Society for Medical Decision Making (Toronto, Canada. October 24-27, 2010). (Abstract)
  4. Westman E, Simmons A, Muehlboeck JS, Gwadry-Sridhar F, Eskildsen SF, et al. Combining Two Large MRI Data Sets (AddNeuroMed and ADNI) Using Multivariate Data Analysis to Distinguish between Patients with Alzheimer’s Disease and Healthy Controls. Alzheimer’s Association International Conference on Alzheimer’s Disease. (2010) IC-P-137. (Abstract)
  5. Zulkernine, F, Martin, P, Zou Y, Bauer M, Gwadry-Sridhar F, Aboulnaga A. Towards Cloud-Based Analytics-as-a-Service (CLAas) for Big Data Analytics in the Cloud. Big Data (BigData Congress), 2013 IEEE International Congress (June 27-July 2, 2013) (Abstract)

Health-Related Quality of Life

  2. Gwadry-Sridhar F, Arnold M, Weaver B, Guyatt G. Does Compliance with ACE-I, Digoxin and Spironolactone Influence the Time to Event in Patients with Heart Failure. Value in Health. 2002; 5(6), PCV37. (Abstract)
  3. Gwadry-Sridhar F, Guyatt G, Weaver B, Arnold M. The Impact of an Educational Intervention on Multiple Health Related Quality of Life Measures in Patients with Heart Failure (HF). Value in Health. 2002; 5(6), PCV44. (Abstract)
  5. Gwadry-Sridhar F, Weaver B, Guyatt G, Arnold M. Is there any relationship between compliance and HRQOL in patients with heart failure? Value in Health. 2002; 5(6):494. (Abstract)
  6. Kawatkar AA, Gwadry-Sridhar F. A Systematic Review of the EORTIC QLQ-BR23: Descriptive Health Related Quality of Life Instrument Used in Breast Cancer. Value in Health. May-June 2006; 9(3): A11, PCN43. (Abstract)
  8. Lou M, Zhou ZY, Gwadry-Sridhar F, Poon JL, Doctor J, Koerper M, Ullman M, Johnson K. Utilizing a Paper Standard Gamble Instrument to Assess Health Utility in Patients with Hemophilia B. Value in Health. May 2011; 14(3): A208, PND33, 2011. (Abstract)
  9. Norman GR, Gwadry-Sridhar F, Guyatt GH, Walter SD. The relation of distribution- and anchor-based approaches on interpretation of changes in health related quality of life. Value in Health. 2001; 4(6):430, # PM125. (Abstract)
  10. Poon JL, Zhou ZY, Doctor JWU, Ullman MM, Ross C, Riske B, Parish KL, Lou M, Koerper M, Gwadry-Sridhar F, Forsberg AD, Curtis RG, Johnson KA. Quality of Life in Haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va). Haemophilia. 2012 Sep; 18(5):699-707. (Abstract)
  11. Stavraky KM, Skillings JR, Stitt LW, Gwadry-Sridhar F. The effect of socioeconomic status on the long-term outcome of cancer. J Clin Epidemiol. 1996 Oct; 49(10):1155-60. (Abstract)
  12. Wang SM, Gwadry-Sridhar F. A systematic overview of the measurement properties of the St. George’s respiratory questionnaire in asthma. Value in Health. 2006; 9(3), PAS10. (Abstract)
  13. Wu J, Globe D, Gwadry-Sridhar F, Forsberg A, Riske B, Johnson KA. The association of barriers to care and health related quality of life in patients with factor VIII deficiency. The Hemophilia Utilization Group Study – Part V. Value in Health. 2007; 10(3):A155, PHM9. (Abstract)
  15. Wu J, Nichol MB, Gwadry-Sridhar F, Johnson KA. The Hemophilia Utilization Group Study – Part V. Estimating Utility Values for Self-Reported Joint Pain and Motion Limitation Outcomes in Adult Hemophilia Patients. Value in Health. May-June 2007; 10(3):A155, PHM8. (Abstract)

Machine Learning

  1. Gwadry-Sridhar F, Bauer M, Lewden B, & Hamou A. A Markov analysis of patients developing sepsis using clusters. In Proceedings of the ECAI 2010 conference on Knowledge representation for health-care (KR4HC’10), Berlin, Heidelberg, 85-100. (Poster)
  2. Hamou A, Simmons A, Bauer M, Lewden B, Zhang Y, et al. Cluster Analysis of MR Imaging in Alzheimer’s Disease using Decision Tree Refinement. International Journal of Artificial Intelligence. 2011; 6(11): 90-9. (Paper)
  3. P. Dai, F. Gwadry-Sridhar, M. Bauer, & M. Borrie. Bagging Ensembles for the Diagnosis and Prognostication of Alzheimer’s Disease. AAAI Conference on Artificial Intelligence (AAAI-16). Phoenix, Arizona, USA, 12-17 Feb, 2016. (Paper)
  4. P. Dai, F. Gwadry-Sridhar, M. Bauer, & M. Borrie. Structural Differences in Cognitively Normal, Mild Cognitive Impairment, and Alzheimer’s Disease Individuals: Alzheimer’s & Dementia. 2015; 11(7): Supplement, Pages P879-P880 (Article)
  5. P. Dai, F. Gwadry-Sridhar, M. Bauer, & M. Borrie. Unveil the hidden Information behind the variables of Alzheimer’s disease (AD): a systematic comparison of Manifold Learning algorithms in AD, in 8th Canadian Conference on Dementia (CCD), Ottawa, Canada, 1-3 Oct, 2015. (Poster)
  6. P. Dai, F. Gwadry-Sridhar, M. Bauer, M. Borrie, & X. Teng. Healthy Cognitive Aging: a hybrid random vector functional-link model for the analysis of Alzheimer’s disease. The Thirty-First AAAI Conference on Artificial Intelligence (AAAI-17), San Francisco, California USA, 4-9 Feb, 2017. (Paper)
  7. P. Dai, F. Gwadry-Sridhar, M. Bauer, M. Borrie, & X. Teng. Longitudinal Brain Structure Changes in Health/MCI Patients: A Deep Learning Approach for the Diagnosis and Prognosis of Alzheimer’s Disease, Alzheimer’s Association International Conference (AAIC), Toronto, ON, Canada, 24-27 July, 2016. (Poster)
  8. S. Nikan, F. Gwadry-Sridhar, & M. Bauer. Machine learning application to predict the risk of coronary artery atherosclerosis, The 2016 International Conference on Computational Science and Computational Intelligence (CSCI’16), Las Vegas, USA, Dec 2016.
  9. S. Nikan, F. Gwadry-Sridhar, & M. Bauer. Pattern recognition application in ECG arrhythmia classification, The 10th International Conference on Health Informatics (HEALTINF2017), Porto, Portugal, Feb 2017. (Accepted)
  10. White JA, Kim HW, Shah D, Fine N, Kim KY, et al. CMR Imaging With Rapid Visual T1 Assessment Predicts Mortality in Patients Suspected of Cardiac Amyloidosis. JACC: Cardiovascular Imaging. Feb 2014; 7(2): 143-156. (Paper)
  11. X. Teng, P. Dai, F. Gwadry-Sridhar, & M. Borrie. Clinical Feature Vs Artificial Intelligence Feature: Risk Factor Analysis Based on Deep Learning, Alzheimer’s Association International Conference (AAIC), Toronto, ON, Canada, 24-27 July, 2016. (Abstract)

Methodology

  1. Alkhawaja S, Martin C, Butler RJ, Gwadry-Sridhar F. Post-pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adult patients. Cochrane Database Syst Rev. 2015 Aug 4; (8):CD008875. (Abstract)
  2. An JJ & Gwadry-Sridhar F. Systematic review of the psychometric properties of the functional assessment of cancer therapy – anemia (Fact-AN) for anemic cancer patients. ISPOR 13th Annual International Meeting (Toronto, Canada. May 3-7, 2008). Value in Health. 2008; 11(3):A164, PSY40. (Abstract)
  3. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010 Mar 24: 303(12):1180-7. (Paper)
  4. Guy S, Ratzki-Leewing A, Gwadry-Sridhar F. Moving Beyond the Stigma: Systematic review of Video Games and Their Potential to Combat Obesity. Int J Hypertens. 2011; 2011: 179124. (Paper)
  5. Gwadry-Sridhar F, Flintoft V, Lee DS, Lee H, Guyatt GH. A systematic Review and Meta-analysis of Studies Comparing Readmission Rates and Mortality Rates in Patients With Heart Failure. Arch Intern Med. 2004 Nov 22; 164(21):2315-20. (Paper)
  6. Gwadry-Sridhar F, Guyatt G, Nadeau L, Calhoun M, Arnold JM. Development of Two Instruments: One to Measure Educational Material Acceptability and One to Measure Knowledge Gained in Patients with Heart Failure. Value in Health. 2001; 4(6):500, # PCV31. (Abstract)
  7. Gwadry-Sridhar F, Guyatt GH, Arnold JM, Massel D, Brown J, Nadeau L, Lawrence S. Instruments to measure acceptability of information and acquisition of knowledge in patients with heart failure. Eur J Heart Fail. 2003 Dec; 5(6): 783-91. (Paper)
  8. Gwadry-Sridhar F, Hamou A, Guy S, O’Brien J, Spence D. Integrated Electronic Medical Health Record Informatics Platform for Stroke and Atherosclerosis Research. Med-e-Tel 2011 (Abstract)
  9. Gwadry-Sridhar F, Lewden B, Mequanint S, & Bauer M. Multi-analytical Approaches Informing the Risk of Sepsis. Biomedical Engineering Systems and Technologies, Springer Communications in Computer and Information Science, 2010, pp. 394-406. (Book Chapter)
  10. Gwadry-Sridhar F, Priestap F, Martin CM, Chen LM, Keenan SP. A survey of Canadian physicians to understand determinants of patient admissions from the emergency room to the intensive care unit. Society for Medical Decision Making 2007 Conference, 29th Annual Meeting SMDM (Pittsburgh, Pennsylvania. Oct 20-24, 2007). Med Decis Making 2007; 27(4): E78, #P3-29. (Abstract)
  11. Gwadry-Sridhar F, Priestap F, Martin CM, Vingilis E, Sridhar K, Devereaux PJ, Hebel L. Development of a service blueprint to study the reasons for variation in mortality of patients with acute myocardial infarction (KIDMI). Society for Medical Decision Making 2007 Conference, 29th Annual Meeting SMDM (Pittsburgh, Pennsylvania. Oct 20-24, 2007). Med Decis Making 2007; 27(4): E86-87, #P4-5. (Abstract)
  12. Gwadry-Sridhar F, Zhang Y, Manias E, Roy AN, Yu-Isenberg K, et al. A framework for planning and critiquing medication compliance and persistence research using prospective study designs. Clin Ther. 2009 Feb; 31(2):421-35. (Paper)
  13. Gwadry-Sridhar FH, Arnold JM, Zhang Y, Brown JE, Marchiori G, Guyatt G. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J. 2005 Nov; 150(5):982. (Paper)
  14. Hamou A, O’Brien J, Guy S, Gwadry-Sridhar F. Intelligent patient management: InfoFrame – An intelligent informatics data collection framework. The 24th International Symposium on Computer-Based Medical Systems, CBMS 2011 (Bristol, United Kingdom. June 27-30, 2011). Computer-Based Medical Systems (CBMS), 2011 24th International Symposium Conference Proceedings. (Abstract)
  15. Hamou A, Simmons A, Bauer M, Lewden B, Zhang Y, et al. Cluster Analysis of MR Imaging in Alzheimer’s Disease using Decision Tree Refinement. International Journal of Artificial Intelligence. 2011 March; 6(11): 90-9. (Paper)
  16. Hiligsmann M, Salas M, Hughes DA, Manias E, Gwadry-Sridhar FH, Linck P, Cowell W. Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporos Int. 2013 Dec; 24(12):2907-18. (Abstract)
  17. Hill A, Gwadry-Sridhar F, Armstrong T, Sibbald W. Development of the continuous quality improvement questionnaire (CQIQ). J Crit Care. 2001 Dec; 16(4): 150-60. (Paper)
  18. Kawatkar AA, Gwadry-Sridhar F. A Systematic Review of the EORTIC QLQ-BR23: Descriptive Health Related Quality of Life Instrument Used in Breast Cancer. Value in Health. May-June 2006; 9(3): A11, PCN43. (Abstract)
  20. Leslie RS, Gwadry-Sridhar F, Thiebaud P, Patel BV. Calculating medication compliance, adherence, and persistence in administrative pharmacy claims databases. Pharmaceutical Programming 2008; 1(1):13-19. (Paper)
  21. Lou M, Zhou ZY, Gwadry-Sridhar F, Poon JL, Doctor J, Koerper M, Ullman M, Johnson K. Utilizing a Paper Standard Gamble Instrument to Assess Health Utility in Patients with Hemophilia B. Value in Health. May 2011; 14(3): A208, PND33, 2011. (Abstract)
  22. Mann R, Gwadry-Sridhar F, Bowman S, Soer J. How to Develop a Common Platform to Enable Interdisciplinary Research. International Journal of Technology, Knowledge & Society 2009; 5(2):21-38. (Paper)
  23. Mann R, Gwadry-Sridhar F, Melquanint S, Martin C. Research Enabling Technology Infrastructure Application. International Journal of Technology, Knowledge & Society. 2010; 6(3):185-206. (Paper)
  24. Norman GR, Gwadry-Sridhar F, Guyatt GH, Walter SD. The Relation of Distribution- and Anchor-Based Approaches on Interpretation of Changes in Health Related Quality of Life. Value in Health, 2001; 4(6):430, # PM125. (Abstract)
  25. Peterson AM, Nau DP, Cramer JP, Benner J, Gwadry-Sridhar F, Nichol M. A Checklist for Medication Compliance and Persistence Studies using Retrospective Databases. Value in Health. January-February 2007; 10(1): 3-12 (Paper)
  26. Sridhar K, Gwadry-Sridhar F, Kidwai B, Almond D, Teefy P. Decision Analysis Model of Acbiximab, Eptifibatide or Standard Therapy in Elective Stent Placement: a Canadian Perspective. Value in Health. 2001; 4(2):107, # PCV34. (Abstract)
  27. Stafkey-Mailey DR, Gwadry-Sridhar F. A Review of the Validity and Reliability of the Parkinson’s Disease Questionnaire (PDQ-39). Value in Health. May-June 2006; 9(3): A88, PNL29, (Abstract)
  28. Westman E, Simmons A, Muehlboeck JS, Gwadry-Sridhar F, Eskildsen SF, et al. Combining Two Large MRI Data Sets (AddNeuroMed and ADNI) Using Multivariate Data Analysis to Distinguish between Patients with Alzheimer’s Disease and Healthy Controls. Alzheimer’s Association International Conference on Alzheimer’s Disease (2010) IC-P-137. (Abstract)
  29. Yu AP, Yu YF, Nichol MB, Gwadry-Sridhar F. Delay in filling the initial prescription for a statin: a potential early indicator of medication non persistence. Clin Ther. 2008 Apr; 30(4):761-74; discussion 716. (Paper)
  30. Zhang Y, Cabilio P, Grubisic M, Gwadry-Sridhar F. A Mixture Distribution Approach to Assessing Medication Refill Compliance with Administrative Pharmacy Refill Records. Statistics in Biopharmaceutical Research, January 2012. (Paper)

Neuroimaging

  1. Braun AR, Balkin TJ, Wesensten NJ, Gwadry F, Carson RE, Varga M, Baldwin P, Belenky G, Herscovitch P. Dissociated pattern of activity in visual cortices and their projections during human rapid eye movement sleep. Science. 1998 Jan 2;279(5347):91-5.
  2. Gwadry F, Berenstein CA, Van Horn J, Braun A. Implementation and Application of Principal Component Analysis on Functional Neuroimaging Data. Institute for Systems Research Technical Report, University of Maryland, TR 2001-47, 2001.

Predictive Analytics

  1. Chen Y, McClintock TR, Segers S, Parvez F, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Ahsan H. Prospective investigation of major dietary patterns and risk of cardiovascular mortality in Bangladesh. Int J Cardiol. 2013 Aug 20;167(4):1495-501. doi: 10.1016/j.ijcard.2012.04.041. Epub 2012 May 4
  2. Chen Y, Wu F, Liu M, Parvez F, Slavkovich V, Eunus M, Ahmed A, Argos M, Islam T, Rakibuz-Zaman M, Hasan R, Sarwar G, Levy D, Graziano J, Ahsan H. A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect. 2013 Jul;121(7):832-8. doi: 10.1289/ehp.1205797. Epub 2013 May 10
  3. Ernst, D., Petrella, T., Joshua, A., Hamou, A., Thabane, M., Vantyghem, S., & Gwadry-Sridhar, F. (2016). Burden of illness for metastatic melanoma in Canada, 2011-2013. Current Oncology, 23(6), e563-e570. (Abstract)
  4. Gwadry-Sridhar F, Olabarriaga SD, Van Kampen A, Bauer M, Solomonides T. Hitting the ground running: Healthgrid deployment and adoption. Stud Health Technol Inform. 2010;159:40-51. (Poster)
  5. Pesola GR, Argos M, Chinchilli VM, Chen Y, Parvez F, Islam T, Ahmed A, Hasan R, Rakibuz-Zaman M, Ahsan H. Dyspnoea as a predictor of cause-specific heart/lung disease mortality in Bangladesh: a prospective cohort study. J Epidemiol Community Health. 2016 Jul;70(7):689-95. doi: 10.1136/jech-2015-206199. Epub 2016 Jan 14
  6. Priestap F, Martin CM, Gwadry-Sridhar F. Does the Time of ICU Discharge Affect Patient Outcomes? Society for Medical Decision Making Annual Meeting. Boston, Massachusetts, United States. (Poster)
  7. Spenger C , Eskildsen S, Sjogren N, Julin P, Westman E, Wahlund LO, Gwadry-Sridhar F, Muehlboech S, Lovestone S, Simmons A. Cortical atrophy rates in Alzheimer’s disease and mild cognitive impairment from the ADNI study. Alzheimer’s & Dementia. July 2011; 7(4): S225. (Abstract)

PROMs

  1. Gee ME, Campbell NRC, Gwadry-Sridhar F, Nolan RP, Kaczorowski J, Bienek A, Robitaille C, Joffres M, Dai S, Walker RL. Antihypertensive Medication Use, Adherence, Stops and Starts in Canadians With Hypertension. Can J Cardiol. 2012 May-June; 28(3):383-9. (Paper)
  2. Hiligsmann M, Salas M, Hughes DA, Manias E, Gwadry-Sridhar FH, Linck P, Cowell W. Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporosis International 2013; 24(12): 2907-2918 (Abstract)
  3. Walker RL, Gee ME, Bancej C, Nolan R, Kaczorowski J, Joffres M, Bienek A, Gwadry-Sridhar F, Campbell NRC. Health Behaviour Advice from Health Professionals to Canadian Adults with Hypertension: Results from a National Survey. Can J Cardiol 2011 Jul; 27(4):446-54. (Abstract)

Value-Based Care

  2. Delorme MA, Gwadry-Sridhar F, Inwood MJ. Prescribing and dispensing practices for oral iron tablets: a Canadian experience. DICP, The Annals of Pharmacotherapy. 1990 Sep; 24(9):874-7. (Paper)
  3. Delorme MA, Inwood MJ, Gwadry-Sridhar F. Enteric-coated iron tablets. CMAJ 1990 Jan 1; 142(1):12-3. (Paper)
  4. Ernst, D., Petrella, T., Joshua, A., Hamou, A., Thabane, M., Vantyghem, S., & Gwadry-Sridhar, F. (2016). Burden of illness for metastatic melanoma in Canada, 2011-2013. Current Oncology, 23(6), e563-e570 (Abstract)
  5. Gwadry-Sridhar F, Priestap F, Martin CM, Vingilis E, Sridhar K, Devereaux PJ, Hebel L. Development of a Service Blueprint to Study the Reasons for Variation in Mortality of Patients with Acute Myocardial Infarction (KIDMI). Society for Medical Decision Making 2007 Conference, 29th Annual Meeting SMDM (Pittsburgh, Pennsylvania. Oct 20-24, 2007). Med Decis Making 2007; 27(4): E86-87, #P4-5. (Abstract)
  7. Gwadry-Sridhar F, Weaver B, Guyatt G, Arnold M. Is there any relationship between compliance and HRQOL in patients with heart failure? Value in Health. 2002; 5(6):494. (Abstract)
  9. Zuluaga A, Salas M, Gwadry-Sridhar F, Manias E, Hughes D. Interventions to Improve Compliance with Lipid Lowering Medications: A Systematic Review of the Literature. Value in Health. May 2010; 13(3): A168. (Abstract)